PLoS ONE 13(3):e0193921 Yang C, Mo Y, Xu E, Wen H, Wei R, Li S, Zheng J, Li W, Le B, Chen Y, Pan H (2019) Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinsons disease mouse model
The CAPTAIN trials demonstrated improved outcomes in moderate to severe injuries, the kind that leave patients unconscious or in altered states of consciousness
For gut-focused protocols, oral capsules 20-30 minutes before meals maximise mucosal contact time
The process is quick and typically causes minimal discomfort
GHK-Cu addresses the secondary tissue concerns that often accompany rapid weight loss: skin laxity, hair thinning, and inflammation